Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine L Cherry

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Plos One|January 5, 2011
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsTudor J C Phillips, Catherine L Cherry, Sarah Cox, et al.
The Clinical Journal of Pain|March 11, 2015
TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory NeuropathyLiesl M Hendry, Antonia L Wadley, Catherine L Cherry, et al.
Disease Markers|November 4, 2011
A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patientsConstance S N Chew, Catherine L Cherry, Adeeba Kamarulzaman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fatCatherine L Cherry, Michelle E Gahan, Justin C McArthur, et al.
Journal of Neurovirology|January 21, 2016
Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patientsHayley Goullee, Antonia L Wadley, Catherine L Cherry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2020
Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without StavudineAhmad Yanuar Safri, Jessica Gaff, Fitri Octaviana, et al.
Australian Journal of Primary Health|June 8, 2018
Consumer engagement critical to success in an Australian research project: reflections from those involvedAnneliese J Synnot, Catherine L Cherry, Michael P Summers, et al.
European Journal of Human Genetics : EJHG|June 5, 2014
Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern AfricansAntonia L Wadley, Liesl M Hendry, Peter R Kamerman, et al.
Immunogenetics|February 25, 2017
A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial diseaseSamuel Halstrom, Catherine L Cherry, Michael Black, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudineCatherine L Cherry, Luxshimi Lal, Katherine A Thompson, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Plos One|January 5, 2011
Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trialsTudor J C Phillips, Catherine L Cherry, Sarah Cox, et al.
The Clinical Journal of Pain|March 11, 2015
TNF Block Gene Variants Associate With Pain Intensity in Black Southern Africans With HIV-associated Sensory NeuropathyLiesl M Hendry, Antonia L Wadley, Catherine L Cherry, et al.
Disease Markers|November 4, 2011
A longitudinal study of the effects of ART on plasma chemokine levels in Malaysian HIV patientsConstance S N Chew, Catherine L Cherry, Adeeba Kamarulzaman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 20, 2002
Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fatCatherine L Cherry, Michelle E Gahan, Justin C McArthur, et al.
Journal of Neurovirology|January 21, 2016
Polymorphisms in CAMKK2 may predict sensory neuropathy in African HIV patientsHayley Goullee, Antonia L Wadley, Catherine L Cherry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 14, 2020
Brief Report: Demographic and Genetic Associations With Markers of Small and Large Fiber Sensory Neuropathy in HIV Patients Treated Without StavudineAhmad Yanuar Safri, Jessica Gaff, Fitri Octaviana, et al.
Australian Journal of Primary Health|June 8, 2018
Consumer engagement critical to success in an Australian research project: reflections from those involvedAnneliese J Synnot, Catherine L Cherry, Michael P Summers, et al.
European Journal of Human Genetics : EJHG|June 5, 2014
Role of TNF block genetic variants in HIV-associated sensory neuropathy in black Southern AfricansAntonia L Wadley, Liesl M Hendry, Peter R Kamerman, et al.
Immunogenetics|February 25, 2017
A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to pulmonary non-tuberculous mycobacterial diseaseSamuel Halstrom, Catherine L Cherry, Michael Black, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Increased adipocyte apoptosis in lipoatrophy improves within 48 weeks of switching patient therapy from Stavudine to abacavir or zidovudineCatherine L Cherry, Luxshimi Lal, Katherine A Thompson, et al.
Pageof 5